Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Literature Commentary

Section Editor(s): Moster, Mark L. MD; Bhatti, M. Tariq MD

doi: 10.1097/WNO.0000000000000731
Literature Commentary: PDF Only

In this issue of Journal of Neuro-Ophthalmology, M. Tariq Bhatti, MD and Mark L. Moster, MD will discuss the following 6 articles:

  • 1. Morrow SA, Fraser JA, Day C, Bowman D, Rosehart H, Kremenchutzky M, Nicolle M. Effect of treating acute optic neuritis with bioequivalent oral vs intravenous corticosteroids: a randomized clinical trial. JAMA Neurol. 2018;75:690–696.
  • 2. Saxena R, Singh D, Sharma M, James M, Sharma P, Menon V. Steroids versus no steroids in nonarteritic anterior ischemic optic neuropathy: a randomized controlled trial. Ophthalmology. 2018;125:1623–1627.
  • 3. Lee PH, Liang CC, Huang SF, Liao HT. The outcome analysis of traumatic facial nerve palsy treated with systemic steroid therapy. J Craniofacial Surg. 2018,29:1842–1847.
  • 4. Schultheiss M, Härtig F, Spitzer MS, Feltgen N, Spitzer B, Hüsing J, Rupp A, Ziemann U, Bartz-Schmidt KU, Poli S. Intravenous thrombolysis in acute central retinal artery occlusion—a prospective interventional case series. PLoS One. 2018;13:e0198114.
  • 5. Dale GH, Petersen T, Bacher Svendsen K, Christensen T, Houen G, Bek T. Time to steroid treatment in severe acute optic neuritis. Brain Behav. 2018 Jun 22 (epub ahead of print).
  • 6. Bilyk JR, Murchison AP, Leiby BT, Sergott RC, Eagle RC, Needleman L, Savino PJ. The utility of color duplex ultrasonography in the diagnosis of giant cell arteritis: a prospective, masked study (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc. 2018;115:T9.
© 2018 by North American Neuro-Ophthalmology Society